Intelligence Β· Patent portfolio
Regeneron Ireland Designated Patents
Full USPTO pharma patent portfolio for Regeneron Ireland Designated β grant dates, expiration, and drug cross-links.
- Patents
- 8,292
- Expiring β€24m
- 426
Quick answer
Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β use filters for patent-cliff planning.
-
US 6858222
Fabrication of drug loaded biodegradable polymer fibers
expired -
US 6855528
Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
expired -
US 6855315
Kits for detecting swine infertility and respiratory syndrome (SIRS) virus
expired -
US 6855804
Covalently reactive transition state analogs and methods of use thereof
expired -
US 6855687
Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
expired -
US 6855340
Copper lowering treatment of inflammatory and fibrotic diseases
expired -
US 6855696
Antitumor agents
expired -
US 6855810
Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof
expired -
US 6852518
Glycosyl sulfotransferases GST-4Ξ±, GST-4Ξ², and GST-6
expired -
US 6852685
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
expired -
US 6852537
Transgenic circulating endothelial cells
expired -
US 6852323
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
expired -
US 6852321
Lectin-derived progenitor cell preservation factor and methods of use
expired -
US 6852318
Methods for detecting and inhibiting angiogenesis
expired -
US 6849602
Compositions for alleviating neuropathic pain with prosaposin receptor agonists
expired -
US 6848211
Cultivated agarwood
expired -
US 6849429
Viral pseudo-capsids including assembly agonists and antagonists
expired -
US 6849605
Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
expired -
US 6849610
Polynucleotide ligands as anti-viral agents
expired -
US 6849712
Peptides with Ξ²1 integrin subunit dependent cell adhesion modulating activity
expired -
US 6846799
Preventing airway mucus production by administration of EGF-R antagonists
expired -
US 6846809
PEI: DNA vector formulations for in vitro and in vivo gene delivery
expired -
US 6846915
Hydroxypyridonate and hydroxypyrimidinone chelating agents
expired -
US 6846817
Nicotine receptor ligands
expired -
US 6846840
Cytotoxic N-unsubstituted indoles and cyclopent(B)indoles and method of making and using same
expired -
US 6846807
Colorectal neoplasia prophylaxis
expired -
US 6846652
Viral vectors having enhanced effectiveness with reduced virulence
expired -
US 6846644
Oncoprotein protein kinase
expired -
US 6846484
DTAT fusion toxin
expired -
US 6846480
Cleaning article containing hydrophilic polymers
expired -
US 6844320
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
expired -
US 6844004
Topical formulations of natamycin/pimaricin
expired -
US 6844175
Methods of inhibition using glycosyl sulfotransferase-3
expired -
US 6841355
Methods and compositions for wound healing
expired -
US 6838437
Inactivation resistant factor VIII
expired -
US 6838443
Antihelminthic anthraquinones and method of use thereof
expired -
US 6838430
Use of HIF-1a variants to accelerate wound healing
expired -
US 6838113
Increasing the digestibility of food proteins by thioredoxin reduction
expired -
US 6838081
Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
expired -
US 6838073
Cobalamin conjugates useful as imaging and therapeutic agents
expired -
US 6835818
Mutants of Streptococcal toxin C and methods of use
expired -
US 6833264
Hyaluronan synthase gene and uses therof
expired -
US 6830749
Recombinant P53 adenovirus methods and compositions
expired -
US 6831093
Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
expired -
US 6831070
Delivery of therapeutic gene products by intestinal cell expression
expired -
US 6828471
Mice models of human prostate cancer
expired -
US 6827935
Method of and compositions for immunization with the pseudomonas V antigen
expired -
US 6825167
Genetic modification of endostatin
expired
Frequently asked questions
How many patents does Regeneron Ireland Designated have?
8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Regeneron Ireland Designated patents expire?
426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory